HIV, Africa and Donald Trump
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
1d
News Medical on MSNNew HIV therapy lenacapavir shows high efficacy in Ugandan populationA multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Elon Musk acknowledged Tuesday that there might not have been a federal plan to spend $50 million on condoms for Gaza – two ...
Majola is one of millions of patients in South Africa affected by U.S. President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection ...
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results